-
1
-
-
38949094248
-
Acute allergic-type reactions among patients undergoing hemodialysis-multiple states, 2007-2008
-
Acute allergic-type reactions among patients undergoing hemodialysis-multiple states, 2007-2008. MMWR Morb Mortal Wkly Rep 2008, 57(5):124-125.
-
(2008)
MMWR Morb Mortal Wkly Rep
, vol.57
, Issue.5
, pp. 124-125
-
-
-
2
-
-
44949233239
-
The FDA and safety-beyond the heparin crisis
-
Laurencin C.T., Nair L. The FDA and safety-beyond the heparin crisis. Nat Biotechnol 2008, 26(6):621-623.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.6
, pp. 621-623
-
-
Laurencin, C.T.1
Nair, L.2
-
3
-
-
34248663609
-
-
U.S.Department of Health and Human Services Online. 2009 November. Available from URL:
-
U.S.Department of Health & Human Services U.S. food and drug administration. Information on adverse event reports and heparin Online. 2009 November. Available from URL:. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM112669.
-
U.S. food and drug administration. Information on adverse event reports and heparin
-
-
-
4
-
-
0025175874
-
Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors
-
Tielemans C., Madhoun P., Lenaers M., Schandene L., Goldman M., Vanherweghem J.L. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 1990, 38(5):982-984.
-
(1990)
Kidney Int
, vol.38
, Issue.5
, pp. 982-984
-
-
Tielemans, C.1
Madhoun, P.2
Lenaers, M.3
Schandene, L.4
Goldman, M.5
Vanherweghem, J.L.6
-
5
-
-
0025221601
-
Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis
-
Verresen L., Waer M., Vanrenterghem Y., Michielsen P. Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 1990, 336(8727):1360-1362.
-
(1990)
Lancet
, vol.336
, Issue.8727
, pp. 1360-1362
-
-
Verresen, L.1
Waer, M.2
Vanrenterghem, Y.3
Michielsen, P.4
-
6
-
-
45149118311
-
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
-
Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 2008, 26(6):669-675.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.6
, pp. 669-675
-
-
Guerrini, M.1
Beccati, D.2
Shriver, Z.3
Naggi, A.4
Viswanathan, K.5
Bisio, A.6
-
7
-
-
0031799877
-
Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation
-
Maruyama T., Toida T., Imanari T., Yu G., Linhardt R.J. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation. Carbohydr Res 1998, 306(1-2):35-43.
-
(1998)
Carbohydr Res
, vol.306
, Issue.1-2
, pp. 35-43
-
-
Maruyama, T.1
Toida, T.2
Imanari, T.3
Yu, G.4
Linhardt, R.J.5
-
8
-
-
44849115945
-
Contaminated heparin associated with adverse clinical events and activation of the contact system
-
Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008, 358(23):2457-2467.
-
(2008)
N Engl J Med
, vol.358
, Issue.23
, pp. 2457-2467
-
-
Kishimoto, T.K.1
Viswanathan, K.2
Ganguly, T.3
Elankumaran, S.4
Smith, S.5
Pelzer, K.6
-
9
-
-
51849150063
-
Contaminated heparin preparations, severe adverse events and the contact system
-
Ramacciotti E., Wahi R., Messmore H.L. Contaminated heparin preparations, severe adverse events and the contact system. Clin Appl Thromb Hemost 2008, 14(4):489-491.
-
(2008)
Clin Appl Thromb Hemost
, vol.14
, Issue.4
, pp. 489-491
-
-
Ramacciotti, E.1
Wahi, R.2
Messmore, H.L.3
-
10
-
-
0023613844
-
The activation of the contact system of human plasma by polysaccharide sulfates
-
Silverberg M., Diehl S.V. The activation of the contact system of human plasma by polysaccharide sulfates. Ann N Y Acad Sci 1987, 516:268-279.
-
(1987)
Ann N Y Acad Sci
, vol.516
, pp. 268-279
-
-
Silverberg, M.1
Diehl, S.V.2
-
11
-
-
0019986914
-
The contact activation mechanism in human plasma: activation induced by dextran sulfate
-
van der Graaf F., Keus F.J., Vlooswijk R.A., Bouma B.N. The contact activation mechanism in human plasma: activation induced by dextran sulfate. Blood 1982, 59(6):1225-1233.
-
(1982)
Blood
, vol.59
, Issue.6
, pp. 1225-1233
-
-
van der Graaf, F.1
Keus, F.J.2
Vlooswijk, R.A.3
Bouma, B.N.4
-
12
-
-
0034809194
-
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma
-
Cyr M., Lepage Y., Blais C., Gervais N., Cugno M., Rouleau J.L., et al. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001, 281(1):H275-H283.
-
(2001)
Am J Physiol Heart Circ Physiol
, vol.281
, Issue.1
-
-
Cyr, M.1
Lepage, Y.2
Blais, C.3
Gervais, N.4
Cugno, M.5
Rouleau, J.L.6
-
13
-
-
38349019673
-
The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes
-
Desormeaux A., Moreau M.E., Lepage Y., Chanard J., Adam A. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials 2008, 29(9):1139-1146.
-
(2008)
Biomaterials
, vol.29
, Issue.9
, pp. 1139-1146
-
-
Desormeaux, A.1
Moreau, M.E.2
Lepage, Y.3
Chanard, J.4
Adam, A.5
-
14
-
-
0031979879
-
Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin
-
Krieter D.H., Grude M., Lemke H.D., Fink E., Bonner G., Scholkens B.A., et al. Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int 1998, 53(4):1026-1035.
-
(1998)
Kidney Int
, vol.53
, Issue.4
, pp. 1026-1035
-
-
Krieter, D.H.1
Grude, M.2
Lemke, H.D.3
Fink, E.4
Bonner, G.5
Scholkens, B.A.6
-
15
-
-
72149085705
-
Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate
-
Keire D.A., Trehy M.L., Reepmeyer J.C., Kolinski R.E., Ye W., Dunn J., et al. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate. J Pharm Biomed Anal 2010, 51(4):921-926.
-
(2010)
J Pharm Biomed Anal
, vol.51
, Issue.4
, pp. 921-926
-
-
Keire, D.A.1
Trehy, M.L.2
Reepmeyer, J.C.3
Kolinski, R.E.4
Ye, W.5
Dunn, J.6
-
16
-
-
61449242663
-
Analysis of heparin sodium by SAX/HPLC for contaminants and impurities
-
Trehy M.L., Reepmeyer J.C., Kolinski R.E., Westenberger B.J., Buhse L.F. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities. J Pharm Biomed Anal 2009, 49(3):670-673.
-
(2009)
J Pharm Biomed Anal
, vol.49
, Issue.3
, pp. 670-673
-
-
Trehy, M.L.1
Reepmeyer, J.C.2
Kolinski, R.E.3
Westenberger, B.J.4
Buhse, L.F.5
-
17
-
-
0028287748
-
Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues
-
Decarie A., Drapeau G., Closset J., Couture R., Adam A. Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 1994, 15(3):511-518.
-
(1994)
Peptides
, vol.15
, Issue.3
, pp. 511-518
-
-
Decarie, A.1
Drapeau, G.2
Closset, J.3
Couture, R.4
Adam, A.5
-
18
-
-
0028987506
-
Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation
-
Raymond P., Drapeau G., Raut R., Audet R., Marceau F., Ong V., et al. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 1995, 180(2):247-257.
-
(1995)
J Immunol Methods
, vol.180
, Issue.2
, pp. 247-257
-
-
Raymond, P.1
Drapeau, G.2
Raut, R.3
Audet, R.4
Marceau, F.5
Ong, V.6
-
19
-
-
0032619714
-
Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P
-
Blais C., Marc-Aurele J., Simmons W.H., Loute G., Thibault P., Skidgel R.A., et al. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides 1999, 20(4):421-430.
-
(1999)
Peptides
, vol.20
, Issue.4
, pp. 421-430
-
-
Blais, C.1
Marc-Aurele, J.2
Simmons, W.H.3
Loute, G.4
Thibault, P.5
Skidgel, R.A.6
-
20
-
-
33847043842
-
Generation of kinins during preparation and storage of whole blood-derived platelet concentrates
-
Moreau M.E., Thibault L., Desormeaux A., Chagnon M., Lemieux R., Robillard P., et al. Generation of kinins during preparation and storage of whole blood-derived platelet concentrates. Transfusion 2007, 47(3):410-420.
-
(2007)
Transfusion
, vol.47
, Issue.3
, pp. 410-420
-
-
Moreau, M.E.1
Thibault, L.2
Desormeaux, A.3
Chagnon, M.4
Lemieux, R.5
Robillard, P.6
-
21
-
-
35548973922
-
B-9972 (D-Arg-[Hyp3, Igl5, Oic7, Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, Igl5, D-Igl7, Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation
-
Bawolak M.T., Gera L., Morissette G., Stewart J.M., Marceau F. B-9972 (D-Arg-[Hyp3, Igl5, Oic7, Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, Igl5, D-Igl7, Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation. J Pharmacol Exp Ther 2007, 323(2):534-546.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, Issue.2
, pp. 534-546
-
-
Bawolak, M.T.1
Gera, L.2
Morissette, G.3
Stewart, J.M.4
Marceau, F.5
-
22
-
-
0032748935
-
Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist
-
Pruneau D., Paquet J.L., Luccarini J.M., Defrene E., Fouchet C., Franck R.M., et al. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology 1999, 43(2-3):187-194.
-
(1999)
Immunopharmacology
, vol.43
, Issue.2-3
, pp. 187-194
-
-
Pruneau, D.1
Paquet, J.L.2
Luccarini, J.M.3
Defrene, E.4
Fouchet, C.5
Franck, R.M.6
-
23
-
-
0035086142
-
Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates
-
Bachvarov D.R., Houle S., Bachvarova M., Bouthillier J., Adam A., Marceau F. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J Pharmacol Exp Ther 2001, 297(1):19-26.
-
(2001)
J Pharmacol Exp Ther
, vol.297
, Issue.1
, pp. 19-26
-
-
Bachvarov, D.R.1
Houle, S.2
Bachvarova, M.3
Bouthillier, J.4
Adam, A.5
Marceau, F.6
-
25
-
-
0024234533
-
-
Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis
-
Nuijens J.H., Huijbregts C.C., Eerenberg-Belmer A.J., Abbink J.J., Strack van Schijndel R.J., Felt-Bersma R.J., et al. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood 1988, 72(6):1841-1848.
-
(1988)
Blood
, vol.72
, Issue.6
, pp. 1841-1848
-
-
Nuijens, J.H.1
Huijbregts, C.C.2
Eerenberg-Belmer, A.J.3
Abbink, J.J.4
Strack van Schijndel, R.J.5
Felt-Bersma, R.J.6
-
26
-
-
0031571319
-
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma
-
Wuillemin W.A., te Velthuis H., Lubbers Y.T., de Ruig C.P., Eldering E., Hack C.E. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J Immunol 1997, 159(4):1953-1960.
-
(1997)
J Immunol
, vol.159
, Issue.4
, pp. 1953-1960
-
-
Wuillemin, W.A.1
te Velthuis, H.2
Lubbers, Y.T.3
de Ruig, C.P.4
Eldering, E.5
Hack, C.E.6
-
27
-
-
0022239271
-
Influence of oral contraceptives and pregnancy on constituents of the kallikrein-kininogen system in plasma
-
Adam A., Albert A., Boulanger J., Genot D., Demoulin A., Damas J. Influence of oral contraceptives and pregnancy on constituents of the kallikrein-kininogen system in plasma. Clin Chem 1985, 31(9):1533-1536.
-
(1985)
Clin Chem
, vol.31
, Issue.9
, pp. 1533-1536
-
-
Adam, A.1
Albert, A.2
Boulanger, J.3
Genot, D.4
Demoulin, A.5
Damas, J.6
-
28
-
-
84945038510
-
Optimized determination of plasma prokallikrein on a Hitachi 705 analyser
-
Adam A., Azzouzi M., Boulanger J., Ers P., Albert A., Damas J., et al. Optimized determination of plasma prokallikrein on a Hitachi 705 analyser. J Clin Chem Clin Biochem 1985, 23(4):203-207.
-
(1985)
J Clin Chem Clin Biochem
, vol.23
, Issue.4
, pp. 203-207
-
-
Adam, A.1
Azzouzi, M.2
Boulanger, J.3
Ers, P.4
Albert, A.5
Damas, J.6
-
29
-
-
58049216683
-
Outbreak of adverse reactions associated with contaminated heparin
-
Blossom D.B., Kallen A.J., Patel P.R., Elward A., Robinson L., Gao G., et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med 2008, 359(25):2674-2684.
-
(2008)
N Engl J Med
, vol.359
, Issue.25
, pp. 2674-2684
-
-
Blossom, D.B.1
Kallen, A.J.2
Patel, P.R.3
Elward, A.4
Robinson, L.5
Gao, G.6
-
30
-
-
0029855363
-
Effects of captopril and icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edema
-
Decarie A., Adam A., Couture R. Effects of captopril and icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edema. Peptides 1996, 17(6):1009-1015.
-
(1996)
Peptides
, vol.17
, Issue.6
, pp. 1009-1015
-
-
Decarie, A.1
Adam, A.2
Couture, R.3
-
31
-
-
0036278146
-
Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach
-
Molinaro G., Gervais N., Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 2002, 33(6):1712-1716.
-
(2002)
Stroke
, vol.33
, Issue.6
, pp. 1712-1716
-
-
Molinaro, G.1
Gervais, N.2
Adam, A.3
-
32
-
-
37849002497
-
Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen
-
Carranza Y.E., Anderson D., Doctor V. Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen. Blood Coagul Fibrinolysis 2008, 19(1):60-65.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, Issue.1
, pp. 60-65
-
-
Carranza, Y.E.1
Anderson, D.2
Doctor, V.3
-
33
-
-
58149132166
-
Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfate
-
Carranza Y.E., Durand-Rougley C., Doctor V. Effect of oversulfation on the chemical and biological properties of chondroitin-4-sulfate. Blood Coagul Fibrinolysis 2008, 19(6):483-487.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, Issue.6
, pp. 483-487
-
-
Carranza, Y.E.1
Durand-Rougley, C.2
Doctor, V.3
-
34
-
-
0032988384
-
Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH
-
Renaux J.L., Thomas M., Crost T., Loughraieb N., Vantard G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int 1999, 55(3):1097-1103.
-
(1999)
Kidney Int
, vol.55
, Issue.3
, pp. 1097-1103
-
-
Renaux, J.L.1
Thomas, M.2
Crost, T.3
Loughraieb, N.4
Vantard, G.5
-
35
-
-
33644645358
-
Guidelines on the use and monitoring of heparin
-
Baglin T., Barrowcliffe T.W., Cohen A., Greaves M. Guidelines on the use and monitoring of heparin. Br J Haematol 2006, 133(1):19-34.
-
(2006)
Br J Haematol
, vol.133
, Issue.1
, pp. 19-34
-
-
Baglin, T.1
Barrowcliffe, T.W.2
Cohen, A.3
Greaves, M.4
-
36
-
-
45849116261
-
[Physiopathology of the acute adverse effects of angiotensin-converting-enzyme inhibitors]
-
Adam A., Desormeaux A., Moreau M.E. Bull Acad Natl Med 2007, 191(7):1443-1444.
-
(2007)
Bull Acad Natl Med
, vol.191
, Issue.7
, pp. 1443-1444
-
-
Adam, A.1
Desormeaux, A.2
Moreau, M.E.3
-
37
-
-
0034889444
-
Absence of ligand-induced regulation of kinin receptor expression in the rabbit
-
Sabourin T., Guay K., Houle S., Bouthillier J., Bachvarov D.R., Adam A., et al. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Br J Pharmacol 2001, 133(7):1154-1162.
-
(2001)
Br J Pharmacol
, vol.133
, Issue.7
, pp. 1154-1162
-
-
Sabourin, T.1
Guay, K.2
Houle, S.3
Bouthillier, J.4
Bachvarov, D.R.5
Adam, A.6
-
38
-
-
61449171129
-
Lessons learned from the contamination of heparin
-
Liu H., Zhang Z., Linhardt R.J. Lessons learned from the contamination of heparin. Nat Prod Rep 2009, 26(3):313-321.
-
(2009)
Nat Prod Rep
, vol.26
, Issue.3
, pp. 313-321
-
-
Liu, H.1
Zhang, Z.2
Linhardt, R.J.3
|